Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma

Liver International

Volumn 27, Issue 7, 2007, Pages 989-996

  Takii, Yasushi ^a,b   Abiru, Seigo ^a,b   Fujioka, Hikaru ^a,b   Nakamura, Minoru ^a,b   Komori, Atsumasa ^a,b   Ito, Masahiro ^a,b   Taniguchi, Ken ^a,b   Daikoku, Manabu ^a,b   Meda, Yumi ^a,b   Ohata, Kazuyuki ^a,b   Yano, Koji ^a,b   Shimoda, Shinji ^c   Yatsuhashi, Hiroshi ^a,b   Ishibashi, Hiromi ^a,b   Migita, Kiyoshi ^a,b  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase; Hepatocellular carcinoma; Prostaglandin E synthase

Indexed keywords

MESSENGER RNA; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E SYNTHASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER SURGERY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34547854357     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01530.x     Document Type: Article

References (38)

1. El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127(Suppl. 1): S27-34.
2. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, et al. Hepatocellular carcinoma: Recent trends in Japan. Gastroenterology 2004; 127: S17-26.
3. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: Current surgical management. Gastroenterology 2004; 127: S248-60.
4. Colombo M, Donato MF. Prevention of hepatocellular carcinoma. Semin Liver Dis 2005; 25: 155-61.
5. Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006; 55: 115-22.
6. Kudo I, Murakami M. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol 2005; 38: 633-8.
7. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-8.
8. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-9.
9. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409-12.
10. Koehne CH, Dubois RN. COX-2 inhibition and colorectal cancer. Semin Oncol 2004; 31: 12-21.
11. Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation. Hepatology 1999; 29: 688-96.
12. Kondo M, Yamamoto H, Nagano H, et al. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin Cancer Res 1999; 5: 4005-12.
13. Murakami M, Nakatani Y, Tanioka T, Kudo I. Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 2002; 68-69: 383-99.
14. Han R, Tsui S, Smith TJ. Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. J Biol Chem 2002; 277: 16355-64.
15. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000; 275: 32775-82.
16. Yoshimatsu K, Altorki NK, Golijanin D, et al. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res 2001; 7: 2669-74.
17. van Rees BP, Sivula A, Thoren S, et al. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. Int J Cancer 2003; 107: 551-6.
18. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
19. Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006; 55: 115-22.
20. Patrono C, Patrignani P, Garcia Rodriguez LA. Cyclooxygenase-selective inhibition of prostanoid formation: Transducing biochemical selectivity into clinical read-outs. J Clin Invest 2001; 108: 7-13.
21. Hull MA. Cyclooxygenase-2: How good is it as a target for cancer chemoprevention? Eur J Cancer 2005; 41: 1854-63.
22. Garavito RM, DeWitt DL. The cyclooxygenase isoforms: Structural insights into the conversion of arachidonic acid to prostaglandins. Biochim Biophys Acta 1999; 1441: 278-87.
23. Turini ME, DuBois RN. Cyclooxygenase-2: A therapeutic target. Annu Rev Med 2002; 53: 35-57.
24. Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 1999; 106: 37S-42S.
25. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 2005; 338: 70-76.
26. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999; 96: 7220-5.
27. Cohen EG, Almahmeed T, Du B, et al. Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma. Clin Cancer Res 2003; 9: 3425-30.
28. van Rees BP, Sivula A, Thoren S, et al. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. Int J Cancer 2003; 107: 551-6.
29. Golijanin D, Tan JY, Kazior A, et al. Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis. Clin Cancer Res 2004; 10: 1024-31.
30. Kamei D, Murakami M, Nakatani Y, Ishikawa Y, Ishii T, Kudo I. Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J Biol Chem 2003; 278: 19396-405.
31. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: Structural, cellular, and molecular biology. Ann Rev Biochem 2000; 69: 145-82.
32. Ristimaki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation. Biochem J 1996; 318(Part 1): 325-31.
33. Murakami M, Kudo I. Prostaglandin E synthase: A novel drug target for inflammation and cancer. Curr Pharm Des 2006; 12: 943-54.
34. Tanabe T, Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002; 68-69: 95-114.
35. Subbaramaiah K, Yoshimatsu K, Scherl E, et al. Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem 2004; 279: 12647-58.
36. Degousee N, Angoulvant D, Fazel S, et al. c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes. J Biol Chem 2006; 281: 16443-52.
37. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 1092-102.
38. Senior K. COX-2 inhibitors: Cancer prevention or cardiovascular risk? Lancet Oncol 2005; 6: 68.